Go Digit’s Strategic Investment in Dr. Reddy’s Laboratories

Go Digit, an insurtech company, has made a notable investment of Rs 30 crore in Dr. Reddy’s Laboratories, acquiring a 0.32% stake in the prominent pharmaceutical firm. According to an exchange filing, Go Digit stated that, “The investment in shares is being made in the ordinary course of the investment function of the company.”

About Dr. Reddy’s Laboratories

Founded in 1984 by Kallam Anji Reddy, Dr. Reddy’s Laboratories operates as an Indian multinational pharmaceutical company dedicated to producing and marketing cost-effective medicines. The company offers a diverse range of products and services, including active pharmaceutical ingredients (APIs), custom pharmaceutical services (CPS), generics, biosimilars, and differentiated formulations.

Overview of Go Digit

Established in 2017 by Kamesh Goyal, Go Digit is a comprehensive digital insurance firm that provides an extensive array of non-life insurance policies encompassing sectors such as automotive, health, travel, and property, among others.

Financial Highlights

For the third quarter of FY25, Go Digit reported a remarkable 176.46% increase in profit after tax (PAT), reaching Rs 118.52 crore year-on-year (YoY), fueled by consistent revenue growth and a managed uptick in operating expenses.

Assets Under Management

As of December 31, 2024, Go Digit’s assets under management totalled Rs 18,939 crore, showcasing the company’s growth trajectory in the insurance sector.

Competitive Landscape

Go Digit faces competition from established players in the market, including Acko, ICICI Lombard, Bajaj Allianz, and Tata AIG, among others.